Oxford PV: tandem solar manufacturing and patent licensing

Oxford PV develops and commercialises perovskite-on-silicon tandem solar technology, combining UK research and development with manufacturing in Germany. Its business includes selling solar products and licensing intellectual property. The company is useful for understanding how an advanced material reaches an established industrial market: efficiency records, customer shipments, factory expansion and patent agreements each represent a different kind of progress, and should be assessed separately.

Origins

University of Oxford spin-out, founded in 2010

Manufacturing location

Brandenburg an der Havel, Germany

Commercial shipment announced

September 2024, to a US customer

Commercial routes

Manufacturing and patent licensing

Research and manufacturing play different roles

Oxford PV's company history identifies its Oxford research site and German pilot and production line. The combination places device development close to the practical work of transferring a technology into manufacturing. This profile concerns Oxford Photovoltaics and its operations; it should not be confused with the separate scientific-instrument company Oxford Instruments.

The industrial question is reproducibility. A successful cell establishes a technical result under its measurement conditions, whereas a saleable module also requires repeatable assembly and a product suitable for the intended customer. Our analytical focus is therefore the sequence of evidence connecting research, production and use. A laboratory record and a commercial product specification are meaningful milestones, but are not interchangeable measures.

What the first shipment demonstrated

In September 2024, Oxford PV announced its first commercial shipment to a US customer. It described 72-cell panels with 24.5% module efficiency and cells produced at its Brandenburg pilot line. The same statement separately mentioned a higher module-efficiency record. Keeping those figures separate avoids presenting a record result as the specification of the shipped product.

The shipment provides evidence that a customer transaction had moved beyond the laboratory. It does not establish industry-wide production volumes, long-term field performance or the economics of a future factory. The company described further scale-up as a plan. For procurement analysis, subsequent evidence on delivered product, manufacturing consistency and sustained service conditions is more useful than projecting future output from that first shipment.

Licensing creates a second commercial route

Oxford PV's April 2025 agreement with Trinasolar granted exclusive patent rights for manufacture and/or sale of perovskite-based photovoltaic products in China, including sublicensing rights. In February 2026, a non-exclusive agreement gave First Solar access to specified patents for potential US manufacturing and distribution, excluding crystalline-silicon semiconductors.

These agreements illustrate why geography, technology scope and exclusivity matter in an industrial licensing model. The First Solar agreement is not evidence that First Solar had adopted Oxford PV's particular silicon-tandem product or begun mass production of it. Our interpretation is that licensing can extend the commercial reach of an intellectual-property portfolio beyond one factory, while manufacturing remains a separate test of execution. Undisclosed fees or future royalty streams should not be inferred from the announcements.